Publication Details
Limiting the risk of cardiac toxicity with esophageal-sparing intensity modulated radiotherapy for locally advanced lung cancers
Woodford K, Panettieri V, Ruben JD, Senthi S
(2016),
J Thorac Dis,
8(5),
A method for verification of treatment delivery in HDR prostate brachytherapy using a flat panel detector for both imaging and source tracking
Smith RL, Haworth A, Panettieri V, Millar JL, Franich RD
(2016),
Med Phys,
43(5),
Pathologic response to neoadjuvant treatment in locally advanced rectal cancer and impact on outcome
Jalilian M, Davis S, Mohebbi M, Sugamaran B, Porter IW, Bell S, Warrier SK, Wale R
(2016),
J Gastrointest Oncol,
7(4),
Long-term outcomes following post-operative radiotherapy for Stage I/II testicular seminoma - an Australasian single-institution experience
Ong WL, Nazareth L, Hindson B, Matheson B, Millar JL
(2016),
J Med Radiat Sci,
63(3),
Development of South Australian-Victorian prostate cancer health outcomes research dataset
Ruseckaite R, Beckmann K, O'Callaghan M, Roder D, Moretti K, Zalcberg J, Millar J, Evans S
(2016),
BMC Res Notes,
9,
Development of an International Prostate Cancer Outcomes Registry
Evans SM, Nag N, Roder D, Brooks A, Millar JL, Moretti KL, Pryor D, Skala M, McNeil JJ
(2016),
BJU Int,
117 Suppl 4,
HIV and renal cell carcinoma: experience in an Australian statewide HIV center
Ong WL, King K, Koh TL, Chipman M, Royce P, Hoy J, Millar JL
(2016),
Asia Pac J Clin Oncol,
12(2),
Eosinophil-associated gene pathways but not eosinophil numbers are differentially regulated between synchrotron microbeam radiation treatment and synchrotron broad-beam treatment by 48 hours postirradiation
Ibahim MJ, Yang Y, Crosbie JC, Stevenson A, Cann L, Paiva P, Rogers PA
(2016),
Radiat Res,
185(1),
Testing the Assessment of New Radiation Oncology Technology and Treatments framework using the evaluation of post-prostatectomy radiotherapy techniques
Duchesne GM, Haworth A, Bone E, Carter H, Ebert MA, Gagliardi F, Gibbs A, Hornby C, Martin A, Sidhom M, Wood M, Jackson M
(2016),
J Med Imaging Radiat Oncol,
60(1),
Variation in lung tumour breathing motion between planning four-dimensional computed tomography and stereotactic ablative radiotherapy delivery and its dosimetric implications: any role for four-dimensional set-up verification?
Ruben JD, Seeley A, Panettieri V, Ackerly T
(2016),
Clin Oncol,
28(1),
Complete pathological response after neoadjuvant long-course chemoradiotherapy for rectal cancer and its relationship to the degree of T3 mesorectal invasion
Wilkins S, Haydon A, Porter I, Oliva K, Staples M, Carne P, McMurrick P, Bell S
(2016),
Dis Colon Rectum,
59(5),
Predictors and rate of adjuvant radiation therapy following radical prostatectomy: a report from the Prostate Cancer Registry
Daniels CP, Millar JL, Spelman T, Sengupta S, Evans SM
(2016),
J Med Imaging Radiat Oncol,
60(2),
Comparison of oncological and health-related quality of life outcomes between open and robot-assisted radical prostatectomy for localised prostate cancer - findings from the population-based Victorian Prostate Cancer Registry
Ong WL, Evans SM, Spelman T, Kearns PA, Murphy DG, Millar JL
(2016),
BJU Int,
118(4),
Dose and gamma-ray spectra from neutron-induced radioactivity in medical linear accelerators following high-energy total body irradiation
Keehan S, Taylor ML, Smith RL, Dunn L, Kron T, Franich RD
(2016),
Radiat Prot Dosim,
172(4),
Radiotherapy in well-differentiated thyroid cancer: is it underutilized?
So K, Smith RE, Davis SR
(2016),
ANZ J Surg,
86(9),
Impact of the lung oncology multidisciplinary team meetings on the management of patients with cancer
Ung KA, Campbell BA, Duplan D, Ball D, David S
(2016),
Asia Pac J Clin Oncol,
12(2),
Pros: should a medically inoperable patient with a T2N0M0 non-small cell lung cancer central in the lung hilus be treated using stereotactic body radiotherapy?
Woodford K, Senthi S
(2015),
Transl Lung Cancer Res,
4(5),
619-22;627–8
Characterising an aluminium oxide dosimetry system
Conheady CF, Gagliardi FM, Ackerly T
(2015),
Australas Phys Eng Sci Med,
38(3),
447-53
High resolution 3D imaging of synchrotron generated microbeams
Gagliardi FM, Cornelius I, Blencowe A, Franich RD, Geso M
(2015),
Med Phys,
42(12),
6973-86
Determination of dose enhancement caused by gold-nanoparticles irradiated with proton, X-rays (kV and MV) and electron beams, using alanine/EPR dosimeters
Smith CL, Ackerly T, Best SP, Gagliardi F, Little PJ, McCorkell G, Sale CA, Tsunei Y, Tominaga T, Volaric SS, Geso M
(2015),
Radiat Meas,
82,
122-8
